Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity

…, O Dufies, A Robert, L Bailly, C Torre, D Chirio… - Blood …, 2021 - ashpublications.org
Dysregulated immune response is the key factor leading to unfavorable coronavirus disease
2019 (COVID-19) outcome. Depending on the pathogen-associated molecular pattern, the …

High prevalence of acquired thrombophilia without prognosis value in patients with coronavirus disease 2019

…, J Dellamonica, V Mondain, D Chirio… - Journal of the …, 2020 - Am Heart Assoc
Background Recent literature reports a strong thrombotic tendency in patients hospitalized
for a coronavirus disease 2019 (COVID‐19) infection. This characteristic is unusual and …

[HTML][HTML] Co-culture of Methanobrevibacter smithii with enterobacteria during urinary infection

G Grine, R Lotte, D Chirio, A Chevalier, D Raoult… - …, 2019 - thelancet.com
Background Urinary tract infections are known to be caused by bacteria, but the potential
implications of archaea have never been studied in this context. Methods In two different …

Effects of standard-dose prophylactic, high-dose prophylactic, and therapeutic anticoagulation in patients with hypoxemic COVID-19 pneumonia: the ANTICOVID …

…, C Saccheri, E Demonchy, D Chirio… - JAMA Internal …, 2023 - jamanetwork.com
Importance Given the high risk of thrombosis and anticoagulation-related bleeding in
patients with hypoxemic COVID-19 pneumonia, identifying the lowest effective dose of …

[HTML][HTML] What about using sniffin'sticks 12 items test to screen post-COVID-19 olfactory disorders?

…, LÉ Dumas, A Plonka, G D'Andréa, D Chirio… - European Archives of …, 2021 - Springer
Background Post-COVID-19 Olfactory impairment has a negative impact on quality of life. The
Sniffin Sticks test 12 items (SST-12) can be used in quick olfactory disorders screening. Its …

[HTML][HTML] Olfactory training in post-COVID-19 persistent olfactory disorders: value normalization for threshold but not identification

…, É Cancian, A Plonka, G D'Andréa, D Chirio… - Journal of Clinical …, 2022 - mdpi.com
(1) Background: Persistent post-viral olfactory disorders (PPVOD) are estimated at 30% of
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …

[HTML][HTML] COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France

…, P Barbry, G Rios, J Dellamonica, D Chirio… - Scientific Reports, 2021 - nature.com
The variant 20I/501Y.V1, associated to a higher risk of transmissibility, emerged in Nice city (Southeast
of France, French Riviera) during January 2021. The pandemic has resumed late …

[HTML][HTML] Correlations between persistent olfactory and semantic memory disorders after SARS-CoV-2 infection

…, M Payne, E Cancian, A Plonka, LÉ Dumas, D Chirio… - Brain sciences, 2022 - mdpi.com
Background: One of the main symptoms of COVID-19 is hyposmia or even anosmia. Olfactory
identification is most often affected. In addition, some cognitive disorders tend to appear …

[PDF][PDF] Persistent olfactory complaints after COVID-19: a new interpretation of the psychophysical olfactory scores

…, V Metelkina-Fernandez, A Plonka, D Chirio… - Rhinol …, 2021 - pdfs.semanticscholar.org
… Clair Vandersteen1, Magali Payne3, Louise-Émilie Dumas2, Victoria Metelkina-Fernandez2,
Alexandra Plonka3,4, David Chirio5, Élisa Demonchy5, Karine Risso5, Florence Askenazy-Gittard2,3 …

[HTML][HTML] Hepatitis rebound after infection with yellow fever virus

B Denis, D Chirio, D Ponscarme, S Brichler… - Emerging infectious …, 2019 - ncbi.nlm.nih.gov
In 2018, yellow fever with hepatitis was diagnosed for 2 unvaccinated travelers returning to
France from Brazil. Hepatitis persisted for> 6 months; liver enzyme levels again increased 2 …